-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Evidence-Based Obstetric Management of Women with Sickle Cell Disease in Low Income Countries

Program: Education Program
Session: Obstetric Management and Complications in Sickle Cell Disease in High- and Low-Income Countries
Hematology Disease Topics & Pathways:
Clinical Trials, Sickle Cell Disease, Epidemiology, Workforce, Diversity, Equity, and Inclusion (DEI) , Hemoglobinopathies, Diseases, Neonatal, Pregnancy, Study Population
Sunday, December 11, 2022, 4:30 PM-5:45 PM

Bosede Afolabi, DM

University of Lagos College of Medicine, Idi-Araba, Nigeria

Disclosures: Afolabi: Bharat Serums and Vaccines, Mumbai, India: Honoraria, Membership on an entity's Board of Directors or advisory committees; Sygen Pharmaceuticals Ltd, Lagos, Nigeria: Membership on an entity's Board of Directors or advisory committees.